Eli Lilly has agreed to acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, including $3.25 billion paid upfront and additional milestone payments tied to clinical, regulatory, and commercial p...
Not financial advice. AIPicks is for learning and research. Data can be delayed. You are responsible for your own decisions and risk. Disclaimer · FAQ.